Seminar Invitation: Pitfalls for SMEs in protecting and claiming incentives for new developments

Presented by:

  • Joe Seisdedos (Wrays)Wrays
  • Glenn Cosgrave (Bates Cosgrave)
  • Adam Rogers (Swanson Reed)

Join Swanson Reed, Bates Cosgrave and Wrays for a practical workshop that will focus on the problems that every day companies face in protecting, and claiming incentives for their new products.

You will hear from three industry experts on a range of topics, including tax issues, R&D tax incentives and patent protection.

On conclusion of the presentation, participants will have an opportunity to ask the panel any specific questions in a friendly and constructive forum.

 

Time Presentation Presenter
7:00am – 7:30am: Session 1: Protecting Intellectual Property (IP) Joe Seisdedos
7:30am – 8:00am: Session 2: IP & Relevant Tax Considerations Glenn Cosgrave
8:00am – 8:30am: Session 3: R&D Tax Incentives Adam Rogers
8:30am – 9:00am: Session 4: Panel Q&A and Networking Opportunity

 

Joe Seisdedos Glenn Cosgrave Adam Rogers
Joe_seisdedos Glenn Cosgrave Adam Rogers

Sydney Seminar:


View Larger Map

Tuesday, 17th June 2014
7am – 9am
Hilton Sydney
488 George Street
Sydney, 2000

Cost: Free!
Register Before:
 Friday 13th June

Register your interest

Full attendance at this workshop will yield 2 CPE hours towards the Tax Practitioners Board’s (TPB) CPE requirements.

Contact Amy Nolan for more information:

Ph: 02 8006 9155
Mob: 0435 713 493

Are you Eligible to claim R&D? Take our R&D Eligibility Survey and find out.

 

Patents, IP, Tax & R&D Tax Incentive Workshop

Latest News

Companies that have the best reputation as innovators aren’t necessarily those that spend the most on R&D

Despite Switzerland being known as one of the most innovative nations, latest reports have shown a 10% decline in the country’s research and development spending. This comes as a surprise due to the fact that worldwide R&D expenditure has reached an all-time high of $782 billion. The biggest Swiss companies invested $27.5 billion into R&D in 2018. The majority of the decline has come from Basel-based giant pharmaceutical companies Roche and Novartis. Roche spent around $1 billion less on R&D […]

Government commitment to pioneer in the life sciences industry by investing into research and development

In 2016 the Johnson & Johnson Partnering Office was launched to enable innovative research and development (R&D) for Queensland’s life sciences industry. The R&D facility is housed at Queensland University of Technology’s (QUT) Institute of Health and Biomedical Innovation. The R&D centre serves as a strong platform to identify and nurture life science and research collaborations. Following on from the launch in 2016, the Queensland government has now announced a significant extension of the Johnson & Johnston R&D Office at […]

Email this job